Email: cspc@cspc.cn

Contact Us

CSPC Holdings Company Limited

News

News

Home > Media > News > VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR THE TREATMENT OF ADVANCED BREAST CANCER OFFICIALLY INI

VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR THE TREATMENT OF ADVANCED BREAST CANCER OFFICIALLY INI

September 24, 2026

Next: VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULT PATIENTS OFFICIALLY INITIATED AT TH

Phone:

+86 311 8703 7015

Email:

Legal terms Privacy protection

Copyright © CSPC PHARMACEUTICAL GROUP LIMITED All Rights Reserved | 冀ICP备05003393号